98 related articles for article (PubMed ID: 4251536)
1. [Conversion rate of (4-14C)dehydroepiandrosterone into ostrone and 17 beta-estradiol in normal as well as toxemic and diabetic placentas].
Lehmann WD
Acta Endocrinol Suppl (Copenh); 1971; 152():42. PubMed ID: 4251536
[No Abstract] [Full Text] [Related]
2. [In vitro-conversion of (4-14C) dehydroepiandrosterone to oestrogens and oestradiol-17-beta by the microsomes of placentae from normal, toxemic and diabetic pregnancies].
Lehmann WD; Misinger J; Lauritzen C
Arch Gynakol; 1971 Apr; 210(1):49-60. PubMed ID: 4251848
[No Abstract] [Full Text] [Related]
3. In vitro conversion of (4-14C) dehydroepiandrosterone and androstenedione to oestrogens by the microsomes of placentas from normal, toxaemic, diabetic and postmature pregnancies.
Lehmann WD; Lauritzen C; Schumann R
Acta Endocrinol (Copenh); 1973 Aug; 73(4):771-89. PubMed ID: 4270460
[No Abstract] [Full Text] [Related]
4. [Proceedings: Aromatization of 4-14C-dehydroepiandrosterone into estrone and estradiol-17-beta by placenta of normal and pathological pregnancies].
Lehmann WD; Lauritzen C
Arch Gynakol; 1973 Sep; 214(1):436-8. PubMed ID: 4273333
[No Abstract] [Full Text] [Related]
5. Progesterone and estradiol production by normal and preeclamptic placentas.
Walsh SW
Obstet Gynecol; 1988 Feb; 71(2):222-6. PubMed ID: 2962026
[TBL] [Abstract][Full Text] [Related]
6. The aromatization of 10-methyl and 10-hydroxymethyl steroids by human placental microsomes.
Wilcox RB; Engel LL
Steroids; 1965; ():Suppl 2:249-55. PubMed ID: 4221182
[No Abstract] [Full Text] [Related]
7. Changes in C19-steroid metabolism by ovine placentas during cortisol administration.
Anderson NG; Curet LB; Colás AE
Biol Reprod; 1978 May; 18(4):643-51. PubMed ID: 148929
[No Abstract] [Full Text] [Related]
8. Biosynthesis of oestrogens and their inter-conversion in human placentae from normal and toxaemic pregnancies.
Rahman SA; Hingorani V; Laumas KR
Clin Endocrinol (Oxf); 1975 Jul; 4(4):333-41. PubMed ID: 125634
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan patterns in diabetic and toxemic term placentas.
Wasserman L; Shlesinger H; Abramovici A; Goldman JA; Allalouf D
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):769-73. PubMed ID: 6778211
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta.
Schwarzel WC; Kruggel WG; Brodie HJ
Endocrinology; 1973 Mar; 92(3):866-80. PubMed ID: 4267111
[No Abstract] [Full Text] [Related]
11. [The influence of prostaglandin F2-alpha and beta-mimetic substances (Th 1165a) on the aromatisation rate in human placentas (author's transl)].
Lehmann WD
Arch Gynakol; 1974; 217(3):251-61. PubMed ID: 4280890
[No Abstract] [Full Text] [Related]
12. Conversion of 4-14C-dehydroepiandrosterone to estrone and 17-beta-estradiol by the rat ovary with observations on variations during the estrous cycle.
Kalvert M; Bloch E
Endocrinology; 1968 May; 82(5):1021-6. PubMed ID: 4231583
[No Abstract] [Full Text] [Related]
13. Metabolism of 4-14C-dehydroepiandrosterone and 4-14C-4-androstene -3, 17-dione by isolated cells of early human placenta.
Dziadkowiec I; Czarnik Z; Rembiesa
Endocrinol Exp; 1977 Mar; 11(1):19-22. PubMed ID: 140044
[TBL] [Abstract][Full Text] [Related]
14. Conversion of dehydroepiandrosterone-7-alpha-3H to oestrogens by corpus luteum, placenta, and placenta plus foetal viscera in early human pregnancy.
Wu CH; Flickinger GL; Touchstone JC
Acta Endocrinol (Copenh); 1967 Jan; 54(1):181-8. PubMed ID: 4224970
[No Abstract] [Full Text] [Related]
15. Fetal considerations. Metabolic clearance rate of maternal plasma dehydroisoandrosterone sulfate.
Worley RJ; Everett RB; Madden JD; MacDonald PC; Gant NF
Semin Perinatol; 1978 Jan; 2(1):15-28. PubMed ID: 153584
[No Abstract] [Full Text] [Related]
16. Proceedings: Oestrogen biosynthesis by subcellular fractions of human placentae from normal and toxaemic pregnancies.
Rahman SA; Hingorani V; Laumas KR
J Reprod Fertil; 1974 May; 38(1):248-9. PubMed ID: 4858278
[No Abstract] [Full Text] [Related]
17. Proceedings: Conversion of dehydroepiandrosterone to oestrogen--a dynamic placental function test.
Jandial V; Varela-Torres R; Klopper A
Br J Obstet Gynaecol; 1975 Mar; 82(3):253. PubMed ID: 124583
[No Abstract] [Full Text] [Related]
18. The placenta in intrauterine fetal deprivation. I. The biochemical profile of placentas from cases of intrauterine growth-retarded gestation of toxemic and non-toxemic origin.
Diamant YZ; Kissilevitz R
Acta Obstet Gynecol Scand; 1981; 60(2):141-7. PubMed ID: 7018162
[No Abstract] [Full Text] [Related]
19. In vitro biosynthesis of estrogens in placentas from normal and toxemic pregnancies.
Laumas KR; Malkani P; Koshti GS; Hingorani V
Am J Obstet Gynecol; 1968 Aug; 101(8):1062-7. PubMed ID: 5663347
[No Abstract] [Full Text] [Related]
20. [Plasma concentration of estrone, estradiol and estriol after dehydroepiandrosterone-sulphate load test in normal and abnormal pregnancy--new discoveries about the kinetics of the DHEA-S test (author's transl)].
Künzig HJ; Geiger W; Gwuzdz P
Z Geburtshilfe Perinatol; 1974 Aug; 178(4):245-53. PubMed ID: 4280662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
